Works matching IS 13866346 AND DT 2025 AND VI 55 AND IP 4


Results: 16
    1
    2
    3
    4
    5
    6

    Antitumor effects and immune‐mediated adverse events of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2025, v. 55, n. 4, p. 577, doi. 10.1111/hepr.14151
    By:
    • Ito, Takanori;
    • Shimose, Shigeo;
    • Tani, Joji;
    • Tomonari, Tetsu;
    • Saeki, Issei;
    • Takeuchi, Yasuto;
    • Hatanaka, Takeshi;
    • Sasaki, Kyo;
    • Kakizaki, Satoru;
    • Kanayama, Yuki;
    • Yoshioka, Naoki;
    • Naito, Takehito;
    • Takeuchi, Mamiko;
    • Yasunaka, Tetsuya;
    • Sakata, Masahiro;
    • Iwamoto, Hideki;
    • Itano, Satoshi;
    • Shirono, Tomotake;
    • Tanabe, Norikazu;
    • Yamamoto, Takafumi
    Publication type:
    Article
    7

    Real‐world efficacy of radiomics versus clinical predictors for microvascular invasion in patients with hepatocellular carcinoma: Large cohort study.

    Published in:
    Hepatology Research, 2025, v. 55, n. 4, p. 567, doi. 10.1111/hepr.14149
    By:
    • Kinoshita, Shotaro;
    • Nakaura, Takeshi;
    • Yoshizumi, Tomoharu;
    • Itoh, Shinji;
    • Ide, Takao;
    • Noshiro, Hirokazu;
    • Hamada, Takashi;
    • Kuroki, Tamotsu;
    • Takami, Yuko;
    • Nagano, Hiroaki;
    • Nanashima, Atsushi;
    • Endo, Yuichi;
    • Utsunomiya, Tohru;
    • Kajiwara, Masatoshi;
    • Miyoshi, Atsushi;
    • Sakoda, Masahiko;
    • Okamoto, Kohji;
    • Beppu, Toru;
    • Takatsuki, Mitsuhisa;
    • Noritomi, Tomoaki
    Publication type:
    Article
    8
    9

    Comparable outcomes among etiologies in early‐stage hepatocellular carcinoma: Analysis of a nationwide registry in Japan.

    Published in:
    Hepatology Research, 2025, v. 55, n. 4, p. 556, doi. 10.1111/hepr.14147
    By:
    • Okushin, Kazuya;
    • Tateishi, Ryosuke;
    • Hirakawa, Shinya;
    • Tachimori, Hisateru;
    • Uchino, Koji;
    • Nakagomi, Ryo;
    • Yamada, Tomoharu;
    • Nakatsuka, Takuma;
    • Minami, Tatsuya;
    • Sato, Masaya;
    • Fujishiro, Mitsuhiro;
    • Hasegawa, Kiyoshi;
    • Eguchi, Yuichiro;
    • Kanto, Tatsuya;
    • Yoshiji, Hitoshi;
    • Izumi, Namiki;
    • Kudo, Masatoshi;
    • Koike, Kazuhiko
    Publication type:
    Article
    10

    Prediction of intrahepatic covalently closed circular DNA levels in patients with resolved hepatitis B virus infection: Impact of serum antibody to hepatitis B core antigen titers.

    Published in:
    Hepatology Research, 2025, v. 55, n. 4, p. 471, doi. 10.1111/hepr.14146
    By:
    • Bae, Sung Kwan;
    • Arita, Junichi;
    • Akamatsu, Nobuhisa;
    • Ichida, Akihiko;
    • Nishioka, Yujiro;
    • Miyata, Akinori;
    • Kawahara, Takuya;
    • Inagaki, Yoshinori;
    • Kawaguchi, Yoshikuni;
    • Kaneko, Junichi;
    • Tamura, Sumihito;
    • Tanaka, Yasuhito;
    • Yotsuyanagi, Hiroshi;
    • Moriya, Kyoji;
    • Hasegawa, Kiyoshi
    Publication type:
    Article
    11
    12
    13

    Circulating and hepatic levels of growth differentiation factor 15 in patients with metabolic dysfunction‐associated steatotic liver disease.

    Published in:
    Hepatology Research, 2025, v. 55, n. 4, p. 492, doi. 10.1111/hepr.14148
    By:
    • Werge, Mikkel Parsberg;
    • Grandt, Josephine;
    • Thing, Mira;
    • Hetland, Liv Eline;
    • Rashu, Elias Badal;
    • Jensen, Anne‐Sofie Houlberg;
    • Junker, Anders Ellekær;
    • Richter, Michael Martin;
    • Møller, Søren;
    • Bendtsen, Flemming;
    • Harder, Lea Mørch;
    • Mazzoni, Gianluca;
    • Viuff, Birgitte Martine;
    • Hvid, Henning;
    • Prada‐Medina, Cesar Augusto;
    • Jørgensen, Sebastian Beck;
    • Bendtsen, Kristian Moss;
    • Kildegaard, Jonas;
    • Vyberg, Mogens;
    • Serizawa, Reza
    Publication type:
    Article
    14
    15
    16

    Issue Information.

    Published in:
    Hepatology Research, 2025, v. 55, n. 4, p. 469, doi. 10.1111/hepr.14066
    Publication type:
    Article